SBC Medical Group Holdings Incorporated
SBCWW · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Valuation | |||
| PEG Ratio | 0.03 | 0.00 | 0.00 |
| FCF Yield | 223.99% | 644.55% | -2,551.96% |
| EV / EBITDA | -1.16 | -0.86 | -1.17 |
| Quality | |||
| ROIC | 21.34% | 21.31% | 3.56% |
| Gross Margin | 75.97% | 70.94% | 65.94% |
| Cash Conversion Ratio | 1.19 | 1.31 | -0.01 |
| Growth | |||
| Revenue 3-Year CAGR | 5.66% | 5,784,301.21% | 5,584,387.45% |
| Free Cash Flow Growth | 31.60% | 257.90% | 0.00% |
| Safety | |||
| Net Debt / EBITDA | -1.46 | -0.93 | -1.20 |
| Interest Coverage | 2,484.23 | 1,560.10 | 639.85 |
| Efficiency | |||
| Inventory Turnover | 33.02 | 18.19 | 43.94 |
| Cash Conversion Cycle | -10.78 | -51.94 | 5.52 |